Top Markets
#1 OSK OSK +15.39%
#2 MarsCoin MarsCoin +12.21%
#3 Tornado Cash Tornado Cash +6.73%
#4 HOME HOME +6.37%
#5 UnifAI Network UnifAI Network +4.86%
#6 AI XOVIA AI XOVIA +4.25%
#7 Pyth Network Pyth Network +3.64%
#8 Backpack Backpack +3.30%
#9 Story Story +3.06%
#10 Rain Rain +2.82%
Coin of the day
OSK OSK
Settings
Language
ENGLISH
Currency
USD
Theme
Sionna Therapeutics, Inc. Sionna Therapeutics, Inc.

Sionna Therapeutics, Inc.

SION
Rank in Stocks #16558
Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is... Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is dedicated to transforming the treatment landscape for individuals with cystic fibrosis. This is achieved by developing innovative medicines designed to restore the normal function of the cystic fibrosis transmembrane conductance regulator.
Share Price
$6.36
Last synced: 2026-09-01
Market Cap
$287.06M
Change (1 day)
5.44%
Change (1 year)
-74.96%
Country
US
Trade Sionna Therapeutics, Inc. (SION)

Category

Healthcare
Earnings for Sionna Therapeutics, Inc. (SION)
Earnings in 2026 TTM: 0
According to Sionna Therapeutics, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Sionna Therapeutics, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH